CLOV vs EMAT · rev $1.37B vs rev $1.6M
Clover Health Investments Corp (CLOV) versus Evolution Metals & Technologies Corp. Common Stock (EMAT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Evolution Metals & Technologies Corp. Common Stock (EMAT) is a other industrial metals & mining company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EMAT revenue for 2026-06-30 was $1.6M. Net income was -$11.9M. Revenue was down 12.9% from 2026-03-31 to 2026-06-30. EMAT currently screens at market cap $4.30B.
CLOV currently screens at market cap $1.55B. EMAT currently screens at market cap $4.30B.
Not investment advice. Open the CLOV and EMAT stock pages for the full models.
Not investment advice.